Get an overview of Pliant Therapeutics’ BEACON-IPF global clinical trial which aims to find out whether bexotegrast slows down or halts idiopathic pulmonary fibrosis disease progression over a 52-week treatment […]

In this educational video, Dr. Émilie Millaire provides an overview of Trevi Therapeutic’s CORAL Phase II clinical trial on chronic cough relating to idiopathic pulmonary fibrosis (IPF). Learn about previous […]

Tune in as Dr. Ciaran Scallan shares how a Canadian Pulmonary Fibrosis (CPFF) research grant helped launch what will soon be the largest prospective study of cough and interstitial lung […]

Dre Charlene Fell, Dre Deborah Assayag et Dre Amanda Grant-Orser, pneumologues, discutent du rôle vital de l’oxygénothérapie pour améliorer la qualité de vie des patients, et de la nécessité d’un […]

Tune in as Dr. Kirsten Nesset shares the impact made by her CPFF Robert Davidson Fellowship, and gives an update on her research project that explores how frailty might impact […]

Tune in as Dr. Shane Shapera shares how CPFF Robert Davidson Fellowships have played a critical role in starting up University Health Network’s (UHN’s) ILD research program, supporting the first […]

In this webinar, Paralympians Brianna Hennessy, Candice Combdon, and Jessica Lewis, each of whom overcame life-altering physical and emotional challenges, share their journeys and inspire hope. Life is filled with […]

This presentation, led by Dr. Donald Zoz MD, senior clinical program leader at Boehringer Ingelheim, provides some insight into FIBRONEER-IPF, a Phase 3 Clinical Trial. The goal of FIBRONEER-IPF Phase […]